Tumor necrosis factor administration is associated with increased endogenous production of M-CSF and G-CSF but not GM-CSF in human cancer patients

Experimental Hematology

Volumn 24, Issue 1, 1996, Pages 49-53

  Logan, T F ^a   Gooding, W ^a   Kirkwood, J M ^a   Shadduck, R K ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Cancer patients; Cytokine network; GM CSF; M CSF; TNF

Indexed keywords

COLONY STIMULATING FACTOR 1; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MITOMYCIN C; TUMOR NECROSIS FACTOR;

ARTICLE; BLOOD LEVEL; CANCER; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL;

COLONIC NEOPLASMS; FIBROMA; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEAD AND NECK NEOPLASMS; HUMANS; KINETICS; MACROPHAGE COLONY-STIMULATING FACTOR; MELANOMA; MITOMYCIN; NEOPLASMS; RECOMBINANT PROTEINS; SARCOMA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030032055     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)